Oral Cyclosporine

DRUG2 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Conditions

Autoimmune DiseaseGlomerular DiseaseKidney TransplantationMembranous GlomerulonephritisNephrotic SyndromeProteinuria

Phase 2

Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

RecruitingNCT00977977

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Autoimmune Disease, Glomerular Disease, Membranous Glomerulonephritis +2

Start: 2010-12-22End: 2027-12-31Target: 30Updated: 2026-09-16

Phase 3

A Study To Test An Anti-Rejection Therapy After Kidney Transplantation

TerminatedNCT00000936

National Institute of Allergy and Infectious Diseases (NIAID)Kidney Transplantation

Start: 1999-11-30End: 2004-03-31Updated: 2017-01-11

Related Papers

Prediagnostic Appearance of Thrombospondin Type-1 Domain 7A Autoantibodies in Membranous Nephropathy

Kidney3602022-11-298 citations